Here, the effect of dasatinib on treatment of Bcr/Abl-positive acute lymphoblastic leukemia (ALL) cells was evaluated in the presence of stromal support. Dasatinib eradicated Bcr/Abl ALL cells ...

B-cell acute lymphoblastic leukemia (B-ALL) is a life-threatening and highly aggressive form of blood cancer. It is the most common childhood cancer, making up 35% of pediatric cancer cases ...

T-cell large granular lymphocytic leukemia (T-LGLL ... Clinical presentation varies across four subtypes: acute, lymphomatous, chronic, and smoldering. Hallmark features include hypercalcemia ...